Frequency of extraintestinal manifestations in patients with inflammatory bowel disease in Northwest Greece and review of the literature

Digestive and Liver Disease

Volumn 34, Issue 11, 2002, Pages 781-786

  Christodoulou, D K ^a   Katsanos, K H ^a   Kitsanou, M ^a   Stergiopoulou, C ^a   Hatzis, J ^a   Tsianos, E V ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Crohn's disease; Extraintestinal manifestations; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

ADULT; AGED; ARTHRALGIA; ARTHRITIS; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CROHN DISEASE; DATA ANALYSIS; DEEP VEIN THROMBOSIS; ENTERITIS; ERYTHEMA NODOSUM; FEMALE; GREECE; HUMAN; IRIDOCYCLITIS; MAJOR CLINICAL STUDY; MALE; NEPHROLITHIASIS; PRIMARY SCLEROSING CHOLANGITIS; RETROSPECTIVE STUDY; SACROILIITIS; SKIN MANIFESTATION; ULCERATIVE COLITIS;

EID: 12244303617     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(02)80071-8     Document Type: Article

References (42)

1. Amati L, Caradonna L, Jirillo E, Caccavo D. Immunological disorders in inflammatory bowel disease and immumotherapeutic implications. Ital J Gastroenterol Hepatol 1999;31:313-25.
2. Kornbluth A, Sachar DB, Salomon P. Crohn's disease. In Feldman M, Scharschmidt BF, Sleisenger MH, editors. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Philadelphia: WB Saunders; 1998. p. 1708-34.
3. Ljunghall S, Ljunggren O. Inflammatory bowel disease and osteoporosis. Ital J Gastroenterol Hepatol 1999;31:103-9.
4. Caprilli R, Viscido A. Evolving concepts on inflammatory bowel disease. Are we happy with the present nosology? Ital J Gastroenterol Hepatol 1999;31:893-7.
5. Brewerton DA, Caffrey M, Nicholls A, Walters D, James DC. HL-A 27 and arthropathies associated with ulcerative colitis and psoriasis. Lancet 1974 18;1:956-8.
6. Palli D, Trallori G, Saieva C, Tarantino O, Edili E, D'Albasio G, et al. General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease. Gut 1998;24:175-9.
7. Baiocco PJ, Gorman BD, Korelitz BJ. Uveitis occurring after colectomy and ileal rectal sleeve anastomosis for ulcerative colitis. Dig Dis Sci 1984;29:570-2.
8. Stenson WF. Inflammatory bowel disease. In: Yamada T, Alpers DH, Laine L, Owyang C, Powell DW, editors. Textbook of Gastroenterology. Third Ed. Baltimore: Lippincott Williams and Wilkins; 1999. p. 1775-839.
9. Plauth M, Jenss H, Meyle J. Oral manifestations of Crohn's disease. J Clin Gastroenterol 1991;13:29-37.
10. Apgar JT. Newer aspects of inflammatory bowel disease and its cutaneous manifestations: a selective review. Semin Dermatol 1991;10:138-47.
11. Basler RSW. Ulcerative colitis and the skin. Med Clin North Am 1980;64:941-54.
12. Thorton JR, Teague RHM, Low-Beer TS, Read AE. Pyoderma gangrenosum and ulcerative colitis. Gut 1980;21:347-8.
13. Levitt MD, Ritchie JK, Lennard-Jones JE, Phillips RKS. Pyoderma gangrenosum in inflammatory bowel disease. Br J Surg 1991;78:676-8.
14. Shum DT, Guenther L. Metastatic Crohn's disease of the skin. Arch Dermatol 1990:126:645-8.
15. Loftus EV jr, Sandborn WJ, Lindor KD, LaRusso NF. Interactions between chronic liver disease and inflammatory bowel disease. Inflamm Bowel Dis 1997:3:288-92.
16. Chapman R. Hepatobiliary Disease. In: Allan RN, Rhodes JM, Hanauer SB, Keighley MRB, Alexander-Williams M, Fazio VW, editors. Inflammatory bowel diseases, 3rd Edition. New York: Churchill Livingstone; 1997. p. 637-46.
17. Yates P, Macht LM, Williams NA, Elson CJ. Red cell autoantibody production by colonic mononuclear cells from a patient with ulcerative colitis and autoimmune haemolytic anaemia. Br J Haematol 1992;82:753-6.
18. Veloso FT, Fraga J, Carvalho J, Dias LM, Salgado MC. Autoimmune hemolytic anemia in ulcerative colitis. A case report with review of the literature. J Clin Gastroenterol 1991;13:445-7.
19. Gumaste V, Greenstein AJ, Meyers R, Sachar DB. Coombs-positive autoimmune hemolyitc anemia in ulcerative colitis. Dig Dis Sci 1989;34:1457-61.
20. Suarez Crespo JF, Nogueras Lopez F, de Teresa Galvan FJ, de Sola Earle CM, Gonzalez Galilea A, Pinel Julian LM, et al. Thromboembolic complications in inflammatory bowel disease. Gastroenterol Hepatol 1997;20:180-3.
21. Hudson M, Chitolie A, Hutton RA, Smith MS, Pounder RE, Wakefield AJ. Thrombotic vascular risk factors in inflammatory bowel disease. Gut 1996;38:733-7.
22. Novacek G, Miehsler W, Kapiotis S, Katzenschlager R, Speiser W, Vogelsang H. Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease. Am J Gastroenterol 1999;94:685-90.
23. Koutroubakis IE, Petinaki E, Anagnostopoulou E, Kritikos H, Mouzas IA, Kouroumalis EA, et al. Anti-cardiolipin and anti-beta2-glycoprotein I antibodies in patients with inflammatory bowel disease. Dig Dis Sci 1998;43:2507-12.
24. Hassan KO, Jenkins HR. Multiple venous thrombosis in inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1998;27:616-7.
25. Deren JJ, Porush JG, Levitt MF, Khilnani MT. Nephrolithiasis as a complication of ulcerative colitis and regional enteritis. Ann Intern Med 1962;56:843.
26. Weiss A, Mayer L. Extraintestinal manifestations of inflammatory bowel disease. In: Allan RN, Rhodes JM, Hanauer SB, Keighley MRB, Alexander-Williams M, Fazio VW, editors. Inflammatory bowel diseases, 3rd Edition. New York: Churchill Livingstone; 1997. p. 623-32.
27. Greenstein AJ, Janowitz HD, Sachar DB. The extraintestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine 1976;55:401-11.
28. Rankin GB. Extraintestinal and systemic manifestations of inflammatory bowel disease. Med Clin North Am 1990;74:39-50.
29. Cottone M, Martorana G, Di Mitri R, Camma C, Caprilli R. Epidemiology of inflammatory bowel disease in Italy. Ital J Gastroenterol Hepatol 1999;31:435-9.
30. Kirsner JB. "Non specific" inflammatory bowel disease (ulcerative colitis and Crohn's disease after 100 years - what next? Ital J Gastroenterol Hepatol 1999;31:651-8.
31. Cucino C. Therapy in inflammatory bowel disease: a double-edged sword. Digest Liver Dis 2002;34:84
32. Danzi T. Extraintestinal manifestations of idiopathic inflammatory bowel disease. Arch Intern Med 1988;148:297-302.
33. Banner MP. Genitourinary complications of inflammatory bowel disease. Radiol Clin North Am 1987;25:199-209.
34. Speiss SE, Braun M, Vogelzgang RL, Craig RM. Crohn's disease of the duodenum complicated by pancreatitis and common bile duct obstruction. Am J Gastroenterol 1992;87:1033-6.
35. Su CG, Stein RB, Lewis JD, Lichtenstein GR. Azathioprine and 6-mercaptopurine for inflammatory bowel disease: do risks out-weight benefits? Digest Liver Dis 2000;32:518-31.
36. Matsuure T, West GA, Levine AD, Fiocchi C. Selective resistance of mucosal T-cell activation to immunosuppression in Crohn's disease. Digest Liver Dis 2000;32:484-94.
37. Angelini G, Cavallini G, Bovo P, Brocco G, Castagnini A, Lavarini E, et al. Pancreatic function in chronic inflammatory bowel disease. Int J Pancreatology 1988;3:85-93.
38. Piontek M, Hengels KJ, Strohmeyer G. Crohn's disease: what about the pancreas? J Clin Gastroenterol 1990;12:491-3.
39. Helzberg JH, Petersen JM, Boyer JL. Improved survival with primary sclerosing cholangitis. Gastroenterology 1987;92:1869-75.
40. Chapman RW, Arborgh BA, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ, et al. Primary sclerosing cholangitis - a review of its clinical features, cholangiography and hepatic histology. Gut 1980;21:870-7.
41. Qasim A, Seery J, O'Morain CA. 5-aminosalicylates in inflammatory bowel disease: choosing the right dose. Digest Liver Dis 2001;33:393-8.
42. Monteleone G, Biancone L, Wedel S, Pallone F. IL-4 hyporesponsiveness of Crohn's disease mucosal T-lymphocytes: a response of polarized Th1 cells? Digest Liver Dis 2000;32:495-7.